GE HealthCare Technologies stock has climbed 19.7% over the past month, yet its valuation checks still lean toward the shares looking cheap rather than stretched. The 19.7% gain over the past month points to a sharp reset in expectations that puts the current pricing under closer scrutiny for new buyers and existing holders. Recent expansion of ultrasound and breast imaging platforms can support expectations for future revenue, while execution risks around new product rollouts may affect how...

GEHC vs. LMAT: Which Stock Is the Better Value Option?

Earlier this month, GE HealthCare introduced the LOGIQ e Xi and LOGIQ e Si laptop ultrasound systems and launched the Invenia ABUS Prime and ABUS StreamVue breast imaging solutions, expanding its AI-enabled and cloud-connected ultrasound portfolio across multiple care settings. These product launches aim to standardize imaging workflows, support remote reading, and address dense-breast screening needs, potentially strengthening GE HealthCare’s position in high-value, technologically advanced...